Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wiltrom CoROCO:6767 -3.60%82 Piotroski F-Score is 5 as of Jul. 15, 2026, which is at its 10-year median of 5.00. GuruFocus rates ROCO:6767 with a GF Score™ of 82/100 and a GF Value™ of NT$29.23 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 802 Medical Devices & Instruments companies, Wiltrom Co ranks better than 65.34% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Wiltrom Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Wiltrom Co's Piotroski F-Score or its related term are showing as below:
ROCO:6767'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 5 Max: 7
Current: 5
During the past 9 years, the highest Piotroski F-Score of Wiltrom Co was 7. The lowest was 3. And the median was 5.
Wiltrom Co (ROCO:6767) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Wiltrom Co Piotroski F-Score Related Terms
Wiltrom Co Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Wiltrom Co's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6767 vs ABT, SYK, MDT: Piotroski F-Score Comparison
For the Medical Devices subindustry, Wiltrom Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wiltrom Co Piotroski F-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Wiltrom Co's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Wiltrom Co's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Wiltrom Co's current Net Income (TTM) was -19.1.
==> Negative ==> Score 0.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Wiltrom Co's return on assets of this year was -0.0260809. Wiltrom Co's return on assets of last year was -0.09858413.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Wiltrom Co's gearing of this year was 0.10959056. Wiltrom Co's gearing of last year was 0.12348077.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Wiltrom Co's current ratio of this year was 8.5702886. Wiltrom Co's current ratio of last year was 7.03752574.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Wiltrom Co's number of shares in issue this year was 39.184. Wiltrom Co's number of shares in issue last year was 39.184.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Wiltrom Co's gross margin of this year was 0.7801324. Wiltrom Co's gross margin of last year was 0.78800227.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Wiltrom Co's asset turnover of this year was 0.42570268. Wiltrom Co's asset turnover of last year was 0.67281871.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
0
+
0
+
1
+
1
+
1
+
1
+
1
+
0
+
0
=
5
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Wiltrom Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.
Wiltrom Co (ROCO:6767) has a Piotroski F-Score of 5 as of Jul. 15, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Wiltrom Co and its competitors. This is near median its historical median of 5.00. Over the past decade, Wiltrom Co's Piotroski F-Score has ranged from 3.00 to 7.00. According to the industry distribution chart, Wiltrom Co ranks #278 out of 802 companies in the Medical Devices & Instruments industry, placing it in the top 34.7%.
Is Wiltrom Co's Piotroski F-Score too high?
Wiltrom Co's current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 7.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Wiltrom Co's value of 5 is 0% at this industry median. Based on the distribution chart, Wiltrom Co ranks #278 out of 802 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Wiltrom Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Wiltrom Co's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Wiltrom Co ranks #278 out of 802 companies for Piotroski F-Score. This puts Wiltrom Co in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Wiltrom Co's value of 5 is 0% at this benchmark. Historically, Wiltrom Co's own Piotroski F-Score has ranged from 3.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Wiltrom Co has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 802 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wiltrom Co's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Wiltrom Co and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wiltrom Co's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wiltrom Co stock overvalued right now?
Based on GuruFocus' analysis, Wiltrom Co (ROCO:6767) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$29.23, compared to a current price of NT$25.45 — trading 12.9% below its estimated fair value. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Medical Devices & Instruments industry median of 5.00. Wiltrom Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Wiltrom Co (ROCO:6767), the current Piotroski F-Score is 5 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wiltrom Co (ROCO:6767) Overvalued in 2026?
Based on GuruFocus' analysis, Wiltrom Co stock appears to be undervalued.
The current stock price of NT$25.45 is trading 12.9% below its estimated GF Value™ of NT$29.23.
GuruFocus considers Wiltrom Co to be Modestly Undervalued.
Key valuation signals for ROCO:6767:
Piotroski F-Score: 5 (near median its 10-year median of 5.00)
GF Value™: NT$29.23 vs. price of NT$25.45 (12.9% below fair value)
Industry Position: 0% at the Medical Devices & Instruments median (#278 of 802)
No single metric tells the full story. See the ROCO:6767 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wiltrom Co Ltd is engaged in research and production of medical devices. Its product portfolio consists of a Spinal fixation system, an Interbody fusion system, a Bone graft substitute, and Vertebral body augmentation system among others.
82GF Score
Get the complete analysis for ROCO:6767
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6767 has been successfully added to your 
